Pefloxacin Mesylate Dihydrate

Pharmaceutical Benefits of Pefloxacin Mesylate Dihydrate

In the field of infectious disease management, this specialized antimicrobial agent offers unique functional advantages due to its ability to inhibit both DNA gyrase and topoisomerase IV. Many pharmaceutical formulators prefer Pefloxacin Mesylate Dihydrate because it remains highly effective against a wide range of Gram-negative and Gram-positive pathogens, including multidrug-resistant strains. Moreover, the mesylate salt form provides enhanced solubility and stability, ensuring optimal bioavailability in final medicinal products. Therefore, the reagent remains a cornerstone in treating gastrointestinal, genitourinary, and respiratory tract infections. Zyntex delivers this product with high assay levels to ensure it integrates seamlessly into your complex synthesis and mixing processes.

Zyntex also supplies high-grade materials for advanced biomedical research and clinical diagnostics. For instance, researchers use this agent as a critical building block for the discovery of new chemical entities and the study of bacterial resistance mechanisms. Additionally, Pefloxacin Mesylate Dihydrate plays a crucial role in veterinary medicine for controlling systemic microbial infections in livestock. In industrial laboratory settings, it serves as a reliable reference standard for susceptibility testing and analytical assays. Consequently, our robust supply chain guarantees that you receive a dependable foundation for innovation. Finally, we provide full technical support and documentation to ensure your facility meets all international regulatory and safety standards.

Key Pefloxacin Mesylate Dihydrate Applications

This versatile pharmaceutical active delivers superior results across these four key technical areas:

Technical Specifications